Mid-Year Report

STANTON PARK GROUP for BARR LABORATORIES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 S.1695, Biologics Price Competition and Innovation Act of 2007 H.R.1038, S.623, Access to Life-Saving Medicine Act H.R. 1908, S.1145, Patent Reform Act of 2007

LobbyistCovered position, as disclosed
BRIAN CAVEY N/A
JAMES DERDERIAN N/A
ANDREW HALATAEI N/A
ERIN STRAWN N/A
ASHLIE VAN METER N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1956 (110th), H.R. 1908 (110th), H.R. 1038 (110th), S. 623 (110th), S. 1145 (110th), S. 1695 (110th)

Consumer Issues/Safety/Products CSP

Generic Drug Settlements S.316, Preserve Access to Affordable Generics Act H.R.1902, Protecting Consumer Access to Generic Drugs Act of 2007

LobbyistCovered position, as disclosed
BRIAN CAVEY N/A
JAMES DERDERIAN N/A
ANDREW HALATAEI N/A
ERIN STRAWN N/A
ASHLIE VAN METER N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1902 (110th), S. 316 (110th)

Pharmacy PHA

H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R. 2900, S.1082, Food and Drug Administration Reform

LobbyistCovered position, as disclosed
BRIAN CAVEY N/A
JAMES DERDERIAN N/A
ANDREW HALATAEI N/A
ERIN STRAWN N/A
ASHLIE VAN METER N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1859 (110th), H.R. 2900 (110th), H.R. 3161 (110th), S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.